Genetic News

Colon cancer patients who have the normal version of a particular gene are more likely to benefit from a combination treatment that includes adding the targeted therapy Erbitux to chemotherapy. Read the rest of this entry »

Chemotherapy may be more effective on melanoma tumors if a protein frequently found in the growth can first be disabled, a new study reports. Read the rest of this entry »

Patients diagnosed with pancreatic cancer - which historically carries a grim prognosis - nearly doubled their overall survival when the cancer drug Gemzar was used after surgery, new research shows. Read the rest of this entry »

The long-awaited results of a trial of the biologic drug Erbitux on patients with advanced non-small cell lung cancer show it prolonged survival by about five weeks when combined with chemotherapy. Read the rest of this entry »